Russian Cancer Vaccine Dissolves Tumors and Metastases

Russian Scientists Report Breakthrough in cancer Vaccine Trials

moscow, Russia – A new cancer vaccine developed by researchers at the Gamaleya Research Institute of Epidemiology and Microbiology⁤ is showing ⁤promising results in preclinical trials, according to the center’s director, Alexandr Gintsburg. ⁢

Gintsburg stated that the vaccine has demonstrated the ability to dissolve tumors and eliminate metastases in melanoma patients.⁣ “In preclinical trials, we see the tumor,⁣ the melanoma, simply ⁤dissolve‍ and disappear,” Gintsburg explained. “Not only the tumor itself, but even the⁢ metastases disappear. I don’t exclude that ‍we may also have patients in the fourth phase ⁢ [of clinical trials].”

The team plans to expand testing to other types of cancer,⁢ including lung, kidney, and ⁢pancreatic cancer, in collaboration with oncology institutes.

personalized Treatment Powered by ⁢AI

This ⁢groundbreaking vaccine is designed to be personalized⁢ for each patient.Artificial intelligence will play a ⁣crucial role in its development, analyzing tumor parameters⁣ to⁣ create a customized treatment plan. Based on this plan, experts can prepare a vaccine within a week.

Leveraging mRNA Technology

The vaccine ⁣utilizes mRNA technology, the same⁤ technology used in COVID-19 vaccines. However, gintsburg emphasized that this vaccine ⁤is⁣ not preventative. “Preventive vaccines are needed‍ for healthy people, and in this case, mRNA technologies work worse because ⁣they produce more side effects,” he explained. ⁣”But if a person is already sick and fighting cancer, the ⁣benefits‍ of mRNA technology outweigh these side effects.”

Breakthrough in Cancer Treatment: Russian Scientists report Promising Results from Personalized Vaccine

Moscow, Russia – In ‍a potential game-changer for⁣ cancer treatment, Russian scientists at ⁣the Gamaleya Research Institute of Epidemiology and Microbiology have announced promising⁤ results from ⁤preclinical ⁤trials of a novel cancer vaccine. The vaccine, which utilizes mRNA technology, has demonstrated the ability to dissolve tumors ⁤and eliminate metastases in melanoma patients, ‍according to the institute’s director, Alexandr Gintsburg.

“In preclinical trials, we see the tumor, the melanoma, simply dissolve‍ and ⁤disappear,” Gintsburg explained. “Not only the tumor itself, ⁢but even the metastases disappear. I don’t exclude that we may also have patients in the fourth phase [of clinical trials].”

The groundbreaking ⁢vaccine⁣ is designed to be personalized for each patient ‍through the use of artificial intelligence (AI). The AI analyzes tumor parameters to create ‍a customized treatment plan, and experts can prepare a vaccine within a week based on this plan.

While the vaccine leverages the same mRNA technology used in COVID-19 vaccines, Gintsburg emphasizes that it is indeed not preventative. ⁣”Preventive vaccines are needed for⁤ healthy people, and in this case, mRNA⁣ technologies work worse because they produce more side effects,” he explained. “But if a person is ⁣already sick and fighting cancer,the benefits of mRNA technology outweigh these side effects.”

The team plans to ⁢expand testing to other ⁤types of cancer, including lung, kidney, and pancreatic‍ cancer, in collaboration with oncology institutes.